ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 30th, 2022 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 29, 2022 (the “Effective Date”), by and between Bluebird Bio, Inc., a corporation organized under the laws of Delaware (“Seller”), and ARGENX BV, a limited liability company organized under the laws of Belgium (“Buyer”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
